PROMISE Registry: PROspective Study on Management of Ischemic Stroke Secondary to mEvo Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorIndiana University
About this trial
Investigators are conducting a real world, observational, prospective, multicenter study to better understand treatment for patients with MeVo and distal vessel occlusions in the U.S post publication of recent MeVO trials.
Eligibility criteria
Qualifiers
Acute ischemic stroke clinically eligible for immediate EVT
Age ≥18 - 85 years of age
Time from onset (or last-seen-well) to 24 hours
Confirmed treatable MeVO based on neurovascular non-invasive imaging (CTA or MRA), at one or more of the following locations: M2 or M3 segment, A2 or A3 segment, P1, P2 or P3 segment
Disqualifiers
Age >86
ASPECTS ≤ 5
Any intracranial hemorrhage on initial CT head non contrast
mRS≥3
Trial design
Treatments tested in this trial
- Not listed
Trial groups
652 Participants
are grouped into 2 trial groupsSponsors and collaborators
Indiana University
Lead sponsor
phenox Inc.
Collaborator
Source ClinicalTrials.gov